Could AlphaFold revolutionize chemical therapeutics?

Autor: Tong AB; Jason L. Choy Laboratory of Single-Molecule Biophysics, Institute for Quantitative Biosciences-QB3, and Chemistry Graduate Group, University of California Berkeley, Berkeley, CA, USA., Burch JD; Ventus Therapeutics, Waltham, MA, USA.; Ventus Therapeutics, Montreal, Canada., McKay D; Ventus Therapeutics, Waltham, MA, USA.; Ventus Therapeutics, Montreal, Canada., Bustamante C; Department of Molecular and Cell Biology, Department of Physics, and Department of Chemistry, Howard Hughes Medical Institute, University of California Berkeley, Berkeley, CA, USA., Crackower MA; Ventus Therapeutics, Waltham, MA, USA.; Ventus Therapeutics, Montreal, Canada., Wu H; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. wu@crystal.harvard.edu.; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA. wu@crystal.harvard.edu.
Jazyk: angličtina
Zdroj: Nature structural & molecular biology [Nat Struct Mol Biol] 2021 Oct; Vol. 28 (10), pp. 771-772.
DOI: 10.1038/s41594-021-00670-x
Databáze: MEDLINE